AcroMeta (SGX:43F) has entered into a side letter extending the exclusivity period for the proposed sale of its 70% stake in its unit Life Science Incubator, according to a Monday filing on the Singapore Exchange.
The new exclusivity period runs until Sept. 30.
The side letter updates certain terms and conditions of the previous non-binding term sheet signed on May 11. Key commercial terms remain unchanged.